The overall aim of this project is to study the molecular mechanisms of the adherence of bacteria to mammalian cells. For this purpose the type 1 fimbria-medicated attached of Escherichia coli and other Enterobacteriaceae will be studied in detail as a paradigm of bacterial adhesion and colonization. Specific efforts will be directed toward: (1) the isolation and purification of the D-mannose binding adhesin (FimH) of E. coli type 1 fimbriae to homogeneity, (2) characterization of the receptor binding properties of the purified FimH adhesin, (3) determining the structural features of FimH that cause it to recognize D-mannose-containing receptors on eukaryotic cells, (4) determining the frequency and range of the distribution of FimH and its gene sequences among type 1 fimbriated members of the family Enterobacteriaceae, and (5) studying the antiadhesive properties of polyclonal and monoclonal antibodies against various genera and species of Enterobacteriaceae in vitro and in vivo in a mouse model of ascending pyelonephritis. The D- mannose binding adhesin will be isolated from FimH overproducing recombinant E. coli transformed with the mutant clone pUT2004 of type 1 fimbriae. The FimH produced by this mutant in the form of fimbriosomes will be isolated from culture supernatants by absorption to and elution from mannan containing yeast cells or by ultrafiltration and gel filtration on columns of Sepharose 4B. The purified FimH in monomeric form or in various sages of polymerization will be assayed for kinetics, D-mannose specificity and affinity of binding to purified D-mannose- containing type 1 fimbrial receptor isolated from guinea pig erythrocytes and immobilized on microtiter plates. The sugar structural specificity of binding will be tested by the inhibition of E. coli or type 1 fimbrial-induced yeast cell or guinea pig erythrocyte agglutination by various D-mannose-containing glycosides and oligosaccharides. Attempts will be made to complement FimH mutants of one species of Enterobacteriaceae with the unaltered gene products of another encoded by a compatible plasmid. Various strains and species of this family will be probed with monoclonal and polyclonal anti-FimH antibodies and its products. Mice will be injected with monoclonal and polyclonal antibodies against intact FimH and synthetic peptides thereof and then challenged intravesically with type 1 fimbriated E. col to determine the protective activity of FimH. These studies should lead to the development of new vaccines against many serious gram-negative bacillary infections in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI013550-16
Application #
3125474
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1976-08-01
Project End
1994-08-31
Budget Start
1991-09-01
Budget End
1992-08-31
Support Year
16
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Barnes-Jewish Hospital
Department
Type
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63110
Malaviya, R; Twesten, N J; Ross, E A et al. (1996) Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 156:1490-6
Malaviya, R; Abraham, S N (1995) Interaction of bacteria with mast cells. Methods Enzymol 253:27-43
Tewari, R; Ikeda, T; Malaviya, R et al. (1994) The PapG tip adhesin of P fimbriae protects Escherichia coli from neutrophil bactericidal activity. Infect Immun 62:5296-304
Malaviya, R; Ross, E A; MacGregor, J I et al. (1994) Mast cell phagocytosis of FimH-expressing enterobacteria. J Immunol 152:1907-14
Malaviya, R; Ross, E; Jakschik, B A et al. (1994) Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice. J Clin Invest 93:1645-53
Bryant, A E; Bergstrom, R; Zimmerman, G A et al. (1993) Clostridium perfringens invasiveness is enhanced by effects of theta toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein. FEMS Immunol Med Microbiol 7:321-36
Tewari, R; MacGregor, J I; Ikeda, T et al. (1993) Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from the periplasm of Escherichia coli. J Biol Chem 268:3009-15
Jones, C H; Pinkner, J S; Nicholes, A V et al. (1993) FimC is a periplasmic PapD-like chaperone that directs assembly of type 1 pili in bacteria. Proc Natl Acad Sci U S A 90:8397-401
Sokurenko, E V; Courtney, H S; Abraham, S N et al. (1992) Functional heterogeneity of type 1 fimbriae of Escherichia coli. Infect Immun 60:4709-19
Ponniah, S; Abraham, S N; Endres, R O (1992) T-cell-independent stimulation of immunoglobulin secretion in resting human B lymphocytes by the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect Immun 60:5197-203

Showing the most recent 10 out of 92 publications